CN Patent

CN105793267B — 环状噻吩并尿嘧啶甲酰胺类及其用途

Assigned to Bayer Pharma AG · Expires 2018-02-06 · 8y expired

What this patent protects

本申请涉及新颖的2,4‑二氧代‑1,2,3,4‑四氢噻吩并[2,3‑d]嘧啶‑6‑甲酰胺衍生物("噻吩并尿嘧啶"‑甲酰胺类)、其制备方法、其单独或组合地用于治疗和/或预防疾病的用途，以及其用于制备用于治疗和/或预防疾病，特别是用于治疗和/或预防肺病和心血管病症的药物的用途。

USPTO Abstract

本申请涉及新颖的2,4‑二氧代‑1,2,3,4‑四氢噻吩并[2,3‑d]嘧啶‑6‑甲酰胺衍生物("噻吩并尿嘧啶"‑甲酰胺类)、其制备方法、其单独或组合地用于治疗和/或预防疾病的用途，以及其用于制备用于治疗和/或预防疾病，特别是用于治疗和/或预防肺病和心血管病症的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105793267B
Jurisdiction
CN
Classification
—
Expires
2018-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.